News About: Pharm. Industry


Pharmaceutical industry restructured

The local pharmaceutical industry already adopted a belt-tightening management policy in an attempt to overcome the IMF economic crisis. The management innovation focused on eliminating marginal products but...

Drug market opening and expansion

A drastic market opening and expansion in the pharmaceutical industry of Korea has been tenaciously requested by the advanced countries. The Amcham. an organization of American Chamber of Commerce stationing in Seou...

Bayer/Hanil M&A talk, rootless rumour?

An M&A news between Bayer and Hanil Pharm. Co. that was rumored quite often recurred in the pharmaceutical community and the stock exchange street recently with keen interests. The rumour originated and ground...

Massive amendment of trademark law permits

OVERVIEW A large scale of the trademark law amendment seems to give an impact to the pharmaceutical industry as well. Along with internationalization movement of the trademark system our government adopted...

Strengthening competitiveness by strategic tie-up

So far a doc business cooperation between a domestic and foreign invested company has been proceeded mainly in aiming to reciprocate and share complementarily their products and sales powers. By taking an oppo...

Pharm. Firms hold shareholder's meeting

OVERVIEW. 13 leading pharmaceutical firms listed in the public stock exchange board including Dong-A, Green-Cross and Yuhan held shareholder's meetings. on Mar. 13th. In the shareholder's meetings, mo...

Sales to retail pharmacy declined

A chronic pharmaceutical recession ensued on remarkable changes in pharmaceutical distribution structures. Since the second half of 1997 the retail pharmacy business backslid and therefore the direct sales deal ...

Strategic tie-up between yuhan and Dong-A

3-year's 10 billion Won investment for development of an anti-osteoporosis drug. Two leading pharmaceutical companies, Yuhan (Representative: Kim Sun-jin) and Dong-A (Representative: Yu Choong-shik) ag...

Management target focused by major pharm.

The leading company executives put the profitability and cash procurement with the most priority on their management target under the IMF financial crisis, it was found in our recent interviews. To acco...

Fair margins pre-requisite to pharmaceutical industrial progress.

President Kim Jeong-soo and Chairman Lee Jang-han (Chongkundang) of the KPMA accepted a courtesy call of Dr. Harvey E. Bale Jr, the Secretary General of the IFPMA, at 11 a.m. on Nov. 13 and shared the opinion of which...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.